In the classification and clinical behavior of lymphoma, Ki-67 serves as an early predictor, not only reflecting tumor aggressiveness and mass size but also showing significant variation in positivity rates across low-, intermediate-, and highly-malignant NHLs. This evidence concerns the gene MKI67 and neoplasm.